Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice.
Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice. PLoS One. 2013; 8(4):e61646.